 | |
 Unpackaged Visine bottle from 2014 | |
| Product type | Eye drops |
|---|---|
| Owner | Kenvue |
| Introduced | 1958 |
| Previous owners | Pfizer Johnson & Johnson |
| Website | www.visine.com |
Visine (/ˌvaɪˈziːn/), also known as Vispring, is a brand of eye drops produced by Kenvue.[1] Visine was first introduced in 1958 and was acquired by Pfizer in 1999.[2][3] In 2006, Johnson & Johnson acquired Visine, along with Pfizer's entire consumer healthcare portfolio.[4] The original formulation of Visine includes the active ingredient tetrahydrozoline hydrochloride, which is a vasoconstrictor that constricts the eye's superficial blood vessels to temporarily reduce eye redness.[5]
- ^ "Johnson & Johnson buys Pfizer consumer unit". NBC News. June 26, 2006. Retrieved January 14, 2023.
- ^ "Covina Argus from Covina, California". Newspapers.com. October 2, 1958.
- ^ "Pfizer Launching Visine Tears for Dry, Irritated Eyes". Medtech Insight. January 8, 1999. Retrieved January 14, 2023.
- ^ Saul, Stephanie (June 27, 2006). "Johnson & Johnson Buys Pfizer Unit for $16.6 Billion". The New York Times. ISSN 0362-4331. Retrieved January 14, 2023.
- ^ "6 Ways to Fix Your Bloodshot Eyes Without Visine". Men's Health. November 20, 2017. Retrieved January 14, 2023.